Challenges in vaccine transport: can we deliver without the cold chain?

Expert Rev Vaccines. 2023 Jan-Dec;22(1):933-936. doi: 10.1080/14760584.2023.2273901. Epub 2023 Oct 27.

Authors

Irnela Bajrovic¹, Maria A Croyle^{2

3}

Affiliations

¹ Jurata Thin Film, Chief Scientific Officer, Houston, TX, USA.
² Division of Molecular Pharmaceutics and Drug Delivery, The University of Texas at Austin College of Pharmacy, Austin, TX, USA.
³ John R. LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin, TX, USA.

PMID: 37861215
DOI: 10.1080/14760584.2023.2273901

No abstract available

Keywords: cold chain; film; formulation; freeze-drying; manufacturing; spray-drying; thermostability; vaccine.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Drug Stability
Humans
Influenza Vaccines*
Powders
Refrigeration*

Substances

Influenza Vaccines
Powders